41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Order of Reference
Extract from the Journals of the Senate, Tuesday, November 22, 2011:
The Honourable Senator Ogilvie moved, seconded by the Honourable Senator Frum:
That the Senate Standing Committee on Social Affairs, Science and Technology be authorized to examine and report on prescription pharmaceuticals in Canada, including but not limited to:
| (a) | the process to approve prescription pharmaceuticals with a particular focus on clinical trials; | |
| (b) | the post-approval monitoring of prescription pharmaceuticals; | |
| (c) | the off-label use of prescription pharmaceuticals; and | |
| (d) | the nature of unintended consequences in the use of prescription pharmaceuticals. |
That the committee submit its final report no later than December 31, 2013, and that the committee retain until March 31, 2014, all powers necessary to publicize its findings.
The question being put on the motion, it was adopted.
Gary W. O’Brien
Clerk of the Senate